Skip to contentW
West Pharmaceutical Services Inc
W
WSTWest Pharmaceutical Services Inc Q1 2015 · 10-Q
Revenue$335.90M$335.90M−3.1% vs Q1 2014 Net Income$32.90M$32.90M+21.4% vs Q1 2014 EPS Diluted$0.45$0.45+18.4% vs Q1 2014 Gross Profit$109,700,000+3.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
Operating Cash Flow-$1,900,000N/M Free Cash Flowderived-$32,300,000N/M Margins · derivedGross margin32.7%+2.0 pt vs Q1 2014
Operating margin14.2%+2.9 pt vs Q1 2014
Net margin9.8%+2.0 pt vs Q1 2014
ended Mar 31, 2015 · filed May 6, 2015 · 36 d after period end